Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but said the eye care unit’s ratings will continue to be under pressure unless the ...

Investing.com -- Fitch Ratings has upgraded the Issuer Default Rating (IDR) of Bausch + Lomb Corporation (BLCO) to ’B’ from ’B-’ on April 17, 2025. The rating on its senior secured debt ...

Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and certain Envistar intraocular lens injector systems, according to the Food ...

The district’s goal throughout the afternoon and evening was to get accurate information to our Pine Ridge Middle School families as quickly as possible. We wish that all of that information had ...

On Wednesday, Fitch Ratings upgraded the Issuer Default Ratings (IDRs) of Bausch Health Companies (NYSE:BHC) Inc. and its subsidiary Bausch Health Americas, Inc. to ’CCC+’ from ’ CCC (WA:CCCP)’. The ...

Bausch Health Companies (BHC) and its gastroenterology business, Salix Pharmaceuticals, announced the U.S. District Court for the District of Columbia in the matter of Norwich Pharmaceuticals, Inc ...

GOBankingRates was able to find each state’s middle-class income range by sourcing the median household income, total population and households. The middle-class income was then calculated using ...

Bausch Health Companies Inc: Bausch "pleased" with court judgment against Norwich Do Bausch Health Companies Inc.: U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and ...

Investing.com -- Fitch Ratings has upgraded the Issuer Default Rating (IDR) of Bausch + Lomb Corporation (BLCO) to ’B’ from ’B-’ on April 17, 2025. The rating on its senior secured debt was also ...

We foresaw a bumpy Q1 and were still surprised by a couple of things. Surprises require updating one's view and incorporating new information. In today's market, that is a continuous process.